ThrombX Retriever for Acute Ischemic Stroke Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT05270122

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
ThrombX Medical (from the registry)
Registry
  • NCT NCT05270122
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05270122. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05 (anticipated); primary completion 2024-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ThrombX Retriever for Acute Ischemic Stroke Trial
Acronym
TRAC
Intervention (Device)
Mechanical thrombectomy with ThrombX Retriever
Lead sponsor
ThrombX Medical (class: industry)

Record details

Record id
cardio:ct-nct05270122
Content hash
f7a89b4b502837144f77c247119f06d15fc7ba75e8b1e76e148dc1ee9c12a4b7